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Etiology of colorectal cancer (CRC) is related, at least in part, with nutritional profile and
epidemiological data indicating a key role of dietary fat on CRC pathogenesis. Moreover,
inflammation and eicosanoids produced from arachidonic acid might have a pivotal role in
CRC development. However, the effect of specific fatty acids (FAs) on intestinal epithelial
cell growth is not completely studied now. By this reason, the aim of this work is to unravel
the effect of different saturated and unsaturated long-chain fatty acids (LCFA) and some
LCFA metabolites on CRC cell line growth and their possible mechanisms of action. Our
results demonstrated that oleic acid is a potent mitogenic factor to Caco-2 cells, at least in
part, through 10-hydroxy-8-octadecenoic synthesized by lipoxigenase pathway, whereas
polyunsaturated FAs such as eicosapentaenoic (EPA) acid has a dual behavior effect
depending on its concentration. A high concentration, EPA induced apoptosis through
intrinsic pathway, whereas at low concentration induced cell proliferation that could be
related to the synthesis of eicosanoids such as prostaglandin E3 and 12-
hydroxyeicosapentaenoic acid and the subsequent induction of mitogenic cell signaling
pathways (ERK 1/2, CREB, p38a). Thus, this study contributes to understand the
complicated relationship between fat ingest and CRC.
Keywords: colorectal cancer, eicosapentaenoic acid, hydroxyeicosapentaenoic acids, oleic acid, prostaglandinINTRODUCTION
Cancer causes around 7 million of deaths annually, becoming 12.5% in the entire world and
colorectal cancer (CRC) is the third leading cause of cancer-related death in developed countries
(Ullman and Itzkowitz, 2011). According to recent rates, the lifetime risk of developing CRC is 4.3%
(NCI). Although a great effort has been made toward developing detection and surgical strategies,
there has been little improvement in the outcome for patients with advanced disease.in.org September 2020 | Volume 11 | Article 5299761
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nutritional profile the major but controllable implicated factors.
In fact, around 90% of the CRC cases appear to be related to
lifestyle, with the highest incidence in economically developed
countries (Clinton et al., 2020). Refined carbohydrates, alcoholic
beverages, red and processed meat, saturated fat, and a high
energy intake, specially associated with abdominal body fatness,
would favor CRC development. In contrast, high consumption of
dietary fiber, fruits and vegetables, calcium, antioxidants, and
vitamins would have the opposite effect (Meyerhardt et al., 2007;
WCRF, 2011). Thus, westernized diet pattern is associated with
an increased risk for CRC (Yusof et al., 2012).
According to the World Health Organization the average
global intake of fat has increased over the last half-century
(WHO). However, not all fats are the same and it is now well
established that saturated, trans fats and unsaturated fats can act in
opposite ways to influence human health, including promotion of
cancer. Thus, the data indicated that not only the amount of
dietary fat but also fat diet composition could be determinant in
the pathogenesis of different neoplasms as CRC (Barone et al.,
2014). Some experimental studies demonstrated that w-3 PUFA
protects against CRC, while w-6 PUFA promotes this cancer
development, proposing mechanisms like modulation of
inflammation, cellular oxidative stress, membrane dynamics, and
cellular receptors function (Larsson et al., 2004; Cockbain et al.,
2012). However, in epidemiological studies there are many
different results, and data seem to be inconclusive regarding the
effect of these FAs on CRC. Some authors demonstrated an
inversely relation between w-3 or w-6 PUFA consumption and
CRC risk (Chao et al., 2005; Norat et al., 2005), others indicated a
lack of association (Sasazuki et al., 2011; Song et al., 2014), while
some shown a positive relationship (Daniel et al., 2009; Shen et al.,
2012). In the other hand, studies including saturated fat
consumption and CRC, demonstrated that there is a direct
relation between these two factors (Giovannucci and Goldin,
1997; Rosignoli et al., 2008) but other authors have not found
any significant relation (Williams et al., 2010. Oleic acid,w-9 FA, is
considered one of the healthier sources of fat in the diet. Also, oleic
acid was attracted much attention as characteristic component of
Mediterranean diet and has been linked to a protector effect
against cancer (Escrich et al., 2007).
Eicosanoids produced from arachidonic acid (AA) might
have a pivotal role in these events. AA biosynthesized from
linoleic acid is the substrate of cyclooxygenase (COX) and
lipoxygenase (LOX) for the production of eicosanoids such as
2-series prostaglandins (PGs), 4-series leukotrienes (LTs) and
HETEs that may facilitate CRC progression by stimulating cell
proliferation and survival, tumor cell invasiveness, and
angiogenesis (Moreno, 2005; Moreno, 2009). PUFAs such as
eicosapentaenoic acid (EPA) can also be released from cell
membrane phospholipids and can act as substrate for COXAbbreviations: AA, arachidonic acid; CCCP, carbonyl cyanide 3-chlorophenylhydrazine;
COX, cyclooxygenase; CRC, colorectal cancer; HEPE, hydroxyeicosapentaenoic acid;
LCFA, long-chain fatty acids; LOX, lipoxygenase; LT, leukotriene; PG, prostaglandin;
SCFA, short-chain fatty acids; TMRE, tetramethylrhodamine ethyl ester.
Frontiers in Pharmacology | www.frontiersin.org 2and LOX pathways, giving rise to the 3-serie PGs, 4-serie LTs,
and hydroxyeicosapentaenoic acids (HEPEs) (Smith, 2005)
which effects on cell proliferation are poorly known.
Considering all together, the effect of FAs on intestinal
epithelial cell growth is not completely understood now. By
this reason, the aim of this study is to determine the effect of
representative saturated and unsaturated long-chain FAs (LCFA)
and some fatty acid metabolites on CRC cell line growth and
their possible mechanisms of action.MATERIAL AND METHODS
Materials
Dulbecco’s modified Eagle’s medium (DMEM), trypsin/EDTA,
penicillin, and streptomycin were supplied by GIBCO (Paisley,
Scotland, UK). Acridine orange, bovine serum albumin (BSA) de-
fatty BSA, carbonyl cyanide 3-chlorophenylhydrazone (CCCP),
Dulbecco’s PBS, ethidium bromide, fetal bovine serum (FBS),
nonessential amino acids, paraformaldehyde extra pure,
propidium iodide, ribonuclease A from bovine pancreas,
SC19220, tetramethylrhodamine ethyl ester perclorate (TMRE),
and Triton X-100 were supplied by Sigma-Aldrich (St. Louis, MO,
USA). 10-hydroxy-8-octadecenoic acid (10-HODE) was from
Parchem (New Rochellem, NY, USA). Tissue culture supplies
and sterile material were obtained from Corning, Nirco S.L.,
NORM-JECT and Biosigma S.R.L. (Italy). The BioRad Protein
Assay was obtained from Bio-Rad Laboratories, Inc. Myristoleic,
palmitoleic, stearic, oleic, elaidic, linoleic, a-linolenic, g-linolenic,
mead, arachidonic (AA), EPA, erucic and DHA acids,
prostaglandin (PG) E2, PGE3, leukotriene (LT) B4, LTB5, 12-S-
HETE, 12-S-HEPE, ketoprofen, baicalein, MK571, MK886
LY171883, zileuton, U75302, and the PPARg ligand screening
assay were supplied by Cayman Chemical Co. (Ann Arbor, MI,
USA). Cell proliferation ELISA–BrdU (Colorimetric) Kit was from
Roche (Basel, Switzerland). LY255283 was from Tocris Biosc.
(Bristol, UK). AH23848 and ONO-329 were kindly provided by
Glaxo-Wellcome (Stevenage, UK) and Ono Pharmaceutical Co.
Ltd. (Osaka, Japan), respectively. The MebStain Apoptosis Kit was
supplied by MBL International (Woburn, MD, USA) and the
Multi Kinase Array (MKA) ElA by Symansis (Auckland,
New Zealand).
Cell Culture
Caco-2 cells were derived from a moderately well-differentiated
primary colon adenocarcinoma and were provided by American
Type Culture Collection (HTB-37) (Manassas, VA, USA). The cells
were routinely grown in 25 or 75 cm2 plastic flasks at a density of
1 × 104 cells/cm2 and cultured in DMEMwith 4.5 g/L D-glucose and
2 mM L-glutamine, and supplemented with 1% (v/v) nonessential
amino acids, 10% (v/v) heat-inactivated FBS, 100 U/ml penicillin,
and 100 µg/ml streptomycin. Cells were incubated at 37°C under a
humidified atmosphere of 5% CO2 in air. Cells grown to ~80%
confluence were released by trypsinization and subcultured at a
density of 1.5–2 × 104 cells/cm2 in 12 mm diameter plastic clusters
and of 1 × 104 cells/cm2 in 60 mm diameter plastic dishes. GrowthSeptember 2020 | Volume 11 | Article 529976
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Caco-2 cells undergo a gradual differentiation process that takes
place spontaneously once confluence has been reached and that is
completed after 21–25 days in culture (Martıń-Venegas et al., 2006).
Considering these, the experiments were performed in cells
maintained for 3 days in culture to use undifferentiated Caco-2
cell cultures to perform all experiments. All experimentation
products were diluted in DMSO (final concentration of DMSO
was lesser than 0.1%). FAs stock solutions prepared in DMSO were
further diluted in cell medium supplemented with FBS or cell
medium containing 5% de-fatty BSA as a carrier to ensure FAs
dissolution. Solutions containing equal amounts of de-fatty BSA
were used as control.
Cell Growth and DNA Synthesis Assays
The effect of the treatments was assessed on Caco-2 cells clusters
in 24-well plates (5–10 × 103 cells/cm2). Cells were cultured for
96 h in DMEM supplemented with 10% FBS. Then, cells were
incubated for 48 h in the presence of treatments. Finally, cells
were washed, trypsinized, and counted under a microscope using
ethidium bromide/acridine orange staining to count viable cells.
DNA synthesis in Caco-2 cells was assessed by a colorimetric
immunoassay based on the measurement of BrdU incorporation
during DNA synthesis (Cell proliferation ELISA, BrdU Kit, from
Roche). Caco-2 cells were cultured at 1,000–1,500 cell/well in 96
well plates for 96 h in DMEM supplemented with 10% FBS. Then,
cells were incubated for 48 h in the presence of compounds.
Thereafter, cells were treated following the manufacturer
instructions. Absorbance was measured at 450 nm in a plate
reader (TECAN, Sunrise, Grödig, Austria).
TUNEL Assay
Degradation of chromosomal DNA was evaluated with TUNEL
method using a MebStain apoptosis kit (MBL Int.). After 96 h in
culture, Caco-2 cells were cultivated in media containing treatments
for 48 h. Next, cells were fixed with 4% paraformaldehyde and
permeabilized with 70% ethanol. Thereafter, 3′-OH DNA ends
generated by DNA fragmentation were labeled with fluorescein-
dUTP, mediated by terminal deoxynucleotidyl transferase, and were
analyzed on an Epics XL flow cytometer (Coulter Corporation, San
Francisco, CA).
PGE2 and PGE3 EIA Determination
PGE2 and PGE3 concentrations were determined in the Caco-2
culture medium. Cells were overnight with FBS or FBS plus EPA
(10 mM). Two hundred fifty ml aliquots of the culture medium were
acidified with 1 ml of formic acid and PGs were extracted in ethyl
acetate. After discarding the aqueous phase, the organic phases were
evaporated under a stream of N2 and PGE2 or PGE3were determined
with a monoclonal enzyme immunoassay kit (MyBiosource, San
Diego, CA) according to the manufacturer’s protocol.
Measurement of Cell Signaling Pathways
Cells were seeded in 60 mm plastic clusters (104 cells/cm2). After
4 days, the cultures were incubated with the treatments inFrontiers in Pharmacology | www.frontiersin.org 3absence of FBS. Maximal phosphorylation was observed after
5 min incubation for ERK1/2, Akt, and p38, and after 15 min for
GSKb and CREB. To measure the kinase activation with total
cellular lysates, Caco-2 cells were lysed using a denaturing cell
lysis buffer containing 6 M urea and protease (leupeptin 2 µg/ml,
pepstatin 10 µM, aprotinin 3 µg/ml) and phosphatase (NaF 5
mM, Na4P2O7 2 mM, Na3VO4 1 mM) inhibitors. The resulting
solutions containing 80–100 µg of proteins were then added to a
kinase ELISA plate and the assay was performed following the
manufacturer’s recommendations (Symansis). Finally, optical
density was measured at 450 nm. Thus, we studied the effect of
PGE2/PGE3 on the phosphorylation of AKT1 (pS473), AKT2
(pS474), ERK1/2 (pT202/Y204; pT185/Y187), GSK3b (pS9),
p38a (pT180/Y182), and CREB (pS133).
PPARg Ligand Assay
FAs binding to PPARg were studied with a fluorescence
polarization-based single-step PPARg ligand screening assay
(Cayman Chem. Co., Ann Arbor, MI, USA). This assay is
based on the competition of free ligand in the samples or
standards for the affinity binding site of PPARg occupied by a
probe conjugated to fluorescein. Finally, the polarization was
quantified as milli-polarization units (mP). This assay was
adapted to be performed in a microcuvette with a luminescence




Mitochondrial membrane depolarization (MMP) was measured
through tetramethylrhodamine ethyl ester perclorate (TMRE)
incorporation into active undifferentiated Caco-2 cell
mitochondria. Carbonyl cyanide 3-chlorophenylhydrazone
(CCCP) was used as a positive control for MMP. Cell cultures
were treated with experimental compounds for 20 min and,
after tripsinization, cell suspension was labeled with TMRE for
30 min. Finally, samples were analyzed in FC500 flow cytometer
(Coulter Corporation) to measure mitochondrial depolarization
or hyperpolarization.
Data Analysis
The results are expressed as mean ± SEM. All data were
compared by one-way ANOVA and the Student’s t-test, using
SPSS software (SPSS Inc., Chicago, IL). Significance was taken as
p < 0.05.RESULTS
Long-Chain Fatty Acids Affect Intestinal
Epithelial Caco-2 Cell Growth
When undifferentiated Caco-2 cells were incubated with different
LCFA in absence of FBS we observed that palmitoleic (10–100 µM),
oleic (1–100 µM), myristoleic (100 µM), and elaidic (100 µM) acids
as well as the lowest EPA and DHA concentration (10 µM) inducedSeptember 2020 | Volume 11 | Article 529976
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stearic did not have this effect. These mitogenic effects of the above-
mentioned monounsaturated FAs (MUFAs) and FUFAs were
confirmed in DNA synthesis analysis except for palmitoleic
(Figure 1B). Interestingly, it can be also seen that highest
concentrations of some FAs like linoleic, a and g-linolenic, AA,
EPA, andDHApromote a decrease in cell number below control cell
group suggesting a cytotoxic or apoptotic action of these PUFAs
(Figure 1A). Then, cells were also incubated with FBS to assess the
proliferative or antiproliferative capacity of these FAs in the presence
of growth factors. Figure 2 shows how oleic acid (1–10 mM)
enhanced the mitogenic effect induced by FBS whereas linoleic, a-
and g-linolenic, and AA decreased cell growth. At 1–10 mMEPA and
DHA did not modify cell growth induced by FBS, whereas at 100
mM the antiproliferative action of these PUFA was confirmed. Thus,
saturated LCFAs did not have any effect on Caco-2 cell growth, oleic
acid was the most mitogenic MUFA assayed; and EPA as a
representative PUFA, presented a dual effect on Caco-2 cell
growth depending on concentration and the presence of FBS.
Polyunsaturated Long-Chain Fatty Acids
Induce Apoptosis in Caco-2 Cell Cultures
Considering that some LCFAs studied have antiproliferative effect
at high concentrations, we analyzed their apoptotic activity by flow
cytometry. Our results show that LCFAs such as a- and g-
linolenic, AA, EPA, and DHA induced apoptosis at high
concentrations whereas oleic acid had no apoptotic activity
(Figure 3). In addition, we measured the capacity of LCFAs to
bind to PPARg and to alter MMP (Table 1). We found thatA
B
FIGURE 1 | Effect of different LCFA on Caco-2 cell growth (A) and DNA synthesis (B) in absence of growth factors. Myristoleic, palmitoleic, stearic, oleic, elaidic,
linoleic, a-linolenic, g-linolenic, mead, AA, EPA, erucic, and DHA were incubated with Caco-2 cells at 1, 10, 50, and 100 µM (dot, gray, line, and black bars,
respectively) without FBS for 48 h and were then counted or DNA synthesis measured by cell BrdU incorporation. Results are expressed like mean ± SEM (n =
8–30). *P < 0.05 versus control group (white bar, cells cultured without FBS).Frontiers in Pharmacology | www.frontiersin.org 4FIGURE 2 | Effect of different LCFA on Caco-2 cell growth in presence of
10% FBS. Oleic, linoleic, a-linolenic, g-linolenic, AA, EPA, and DHA were
incubated with Caco-2 cells at 1, 10, and 100 µM (dot, gray, and black bars,
respectively) in presence of 10% FBS for 48 h and were then counted.
Results are expressed like mean ± SEM (n = 4–12). *P < 0.05 vs. control
group (white bar, cells cultured with 10% FBS).September 2020 | Volume 11 | Article 529976
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affinity to PPARg. Furthermore, AA, EPA, and DHA were capable
to induce significant changes ofMMP, both parameters implicated
in the denominated intrinsic or mitochondrial pathway of
apoptosis. Interestingly, low g-linolenic, EPA, and DHA
concentrations (10 mM) were not able to bind to PPARg and to
alter MMP (Table 1).
The Mitogenic Effect of Oleic Acid and
EPA Can Be Related With Cyclooxygenase
and Lipoxygenase Metabolite Release
Undifferentiated Caco-2 cells expresses COX-1 and COX-2
(Martin-Venegas et al., 2006), 5-, 12-, and 15-LOX (Martin-
Venegas et al., 2014) as well as BLT receptors (Martin-Venegas
et al., 2014) and EP receptors (Rodriguez-Lagunas et al., 2010).
Here, we observed that cell proliferation induced by oleic acid or
EPA at 10 µM was reverted by MK886 (5-LOX inhibitor),
baicalein (12-LOX inhibitor), U75302 (BLT1 antagonist), and
LY255283 (BLT1 and BLT2 antagonist) (Figure 4). In addition,
these experiments showed that ketoprofen (COX inhibitor),
AH23838 (EP4 antagonist), SC19220 (EP1 antagonist) also
reverted the mitogenic effect induced by EPA (Figure 4)
whereas the mitogenic effect induced by oleic acid was
similarly reverted by MK571 (cysteinyl leukotriene antagonist)
and LY171883 (cysteinyl LT receptor antagonist) (Figure 4). All
inhibitors and antagonists were used to optimal concentrations
previously stablished (Cabral et al., 2013). The reversion of oleic/
EPA mitogenic effects by AA cascade inhibitors and eicosanoid
receptor antagonists suggests a role of oleic/EPA metabolites in
the mitogenic effects induced by both FAs.Frontiers in Pharmacology | www.frontiersin.org 5Eicosanoids From EPA Such as PGE3 and
12-S-HEPE Are Mitogenic Whereas LTB5
Did Not Induce Caco-2 Cell Growth
EPA can be presented into cell membrane phospholipids (Lands
et al., 1992), it is release by phospholipases (Nieves and Moreno,
2006), and it is metabolized by COX and LOX, giving rise to theA
B
FIGURE 3 | Effect of different LCFA on Caco-2 cell apoptosis. Caco-2 cells
were incubated with stearic, oleic, linoleic, a-linolenic, g-linolenic, AA, EPA,
and DHA at 100 µM (black bars) in absence (A) or presence of FBS (B) for
48 h and DNA fragmentation was measured. Values are mean ± SEM (n =
3–8). *P < 0.05 versus negative control group (cells cultured in absence of
FBS, white bar). As positive control we used staurosporine (1 µM) in presence
of 10% FBS (white bar).TABLE 1 | Effect of LCFAs on PPARg ligand assay and mitochondrial membrane
potential variation.
Treatment PPARg bind (mP) DMMP (au)
Vehicle 108 ± 9 21 ± 1.9
Rosiglitazone (10 mM) 43 ± 2* ND
CCCP (5 mM) ND 6 ± 0.5*
Staurosporine (1 mM) ND 70 ± 4*
Oleic (100 mM) 109 ± 12 21 ± 1.6
Linoleic (100 mM) 98 ± 10 22 ± 0.7
a-Linolenic (100 mM) 76 ± 8* 24 ± 0.2
g-Linolenic (10 mM) 91 ± 8 22 ± 0.7
g-Linolenic (100 mM) 71 ± 16* 22 ± 0.9
AA (100 mM) 70 ± 8* 28 ± 1.9*
EPA (10 mM) 89 ± 7 23 ± 1,3
EPA (100 mM) 63 ± 15* 34 ± 1.3*
DHA (10 mM) 82 ± 7 25 ± 0.9
DHA (100 mM) 56 ± 3* 38 ± 0.7*September 2020 | Volume 11 | ArPPARg binding was measured by fluorescence polarization and mitochondrial membrane
potential variation (DMMP) was measured by flow cytometry as Material and Methods
section described and was expressed as mP and arbitrary units (au), respectively. Results
are expressed as mean ± SEM (n = 3–5). *P < 0.05 versus control group (vehicle). ND,
non determined.FIGURE 4 | Effect of pharmacological modulation of AA cascade on Caco-2
cell growth induced by oleic and EPA. Caco-2 cells were incubated without
FBS for 48 h with oleic or EPA at 10 µM in presence or absence of
ketoprofen (Kp, 5 µM), AH23848 (AH23, 20 nM), SC19220 (SC19, 60 nM),
baicalein (Bai, 25 µM), MK886 (MK8, 10 µM), U75302 (U75, 5 µM), LY25283
(LY25, 25 µM), MK571 (MK5, 25 µM), or LY171883 (LY17, 25 µM) and cells
were counted. Results are expressed as mean ± SEM (n = 8–16). *P < 0.05
vs. control group (white bar, cells cultured without FBS), #P < 0.05 versus
oleic acid (10 µM), and §P < 0.05 versus EPA (10 µM).ticle 529976
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(Dommels et al., 2002). Our results show that PGE2
concentrations in Caco-2 cell culture medium reach 1.52 ±
0.21 ng/ml (around 5 nM) whereas PGE3 was not detected.
Interestingly, EPA (10 mM) supplementation of Caco-2 cell
culture medium increases PGE3 synthesis (1.02 ± 0.13 ng/ml),
whereas we observed the impairment of PGE2 (1.02 ± 0.09 ng/
ml). In Figures 5A, B we observed that PGE3 progressively
increased Caco-2 cell growth and DNA synthesis up to 10 nM in
a similar way to PGE2. Figures 5A, B also show that Caco-2 cell
growth and DNA synthesis induced by PGE3 was totally
inhibited by an EP1 antagonist (SC19220) and by an EP4
antagonist (AH23838). However, an EP3 antagonist (ONO-
AE3-240, 2nM) did not have any effect. Therefore, these results
indicate that PGE3 acts through EP1 and EP4 receptors, but not
through the EP3 receptor.
Our results also show that 12-S-HEPE (100–1000 nM)
induced significant cell growth and DNA synthesis in Caco-2
cell cultures in the absence of growth factors, in a similar way to
12-S-HETE (100 nM). This mitogenic action of 12-S-HEPE was
blocked by a COX inhibitor (ketoprofen), by a BLT1 antagonistFrontiers in Pharmacology | www.frontiersin.org 6(U75302), and by a BLT1 and BLT2 antagonist (LY255283)
(Figures 5C, D).
Previously we observed that LTB4 has a mitogenic effect on
Caco-2 cells (Cabral et al., 2013). However, our findings show
that LTB5 derived from EPA did not induce proliferation in the
range of 1–100 nM (Figure 5E).
Finally, we studied the capacity of PGE3 (10 nM) and 12-S-
HEPE (100 nM) to phosphorylate pivotal elements in the cell
signaling pathways implicated in the regulation of cell growth.
Our findings show that PGE3 presents a similar pattern to PGE2.
Thus, PGE3 could increase the phosphorylation of ERK 1/2,
CREB, GSKb, and p38a (Table 2), cell signaling pathways
involved in cell growth. Similar effects were induced by 12-S-
HEPE (Table 2).
10-Hydroxy-8-Octadecenoic, LOX-
Metabolite From Oleic Acid, Has
Proliferative Effect in Caco-2 Cultures
Guerrero et al. (1997) and Clapp et al. (2006) reported the
oxidation of oleic acid by bacterial and vegetal LOXs to
produce 10-hydroxy-8-octadecenoic (10-HODE). Considering
that undifferentiated Caco-2 cells have 5-, 12-, and 15-LOX
activities (Cabral et al., 2013; Martin-Venegas et al., 2014), we
hypothesized the implication of 10-HODE in the mitogenic
effects of oleic acid. Our results show that 10-HODE acid
induced significant cell growth and DNA synthesis in Caco-2
cell cultures in the absence of growth factors, in a similar way to
oleic acid. This mitogenic action of 10-HODE was blocked by a
BLT1 antagonist (U75302), but not by BLT1 and BLT2 antagonist
(LY255283) nor by MK571, a cysteinyl leukotriene antagonist
(Figure 6). Furthermore, we observed that 10-HODE was able to
induce some mitogenic cell signaling pathways such as ERK 1/2,
CREB, or p38a (Table 2).DISCUSSION
Undigested carbohydrates are fermented in the large intestine to
form short-chain fatty acids (SCFA) such as acetate, propionate,
and butyrate. SCFAs and specially butyrate induces cellular
differentiation and decrease proliferation of CRC-derived cell
lines (Hass et al., 1997; Arantes et al., 2016). These effects may
be related with the inhibition of histone deacetylase by DNA
hypermethylation to promote cell differentiation (Boffa et al.,
1978) and the inhibition of cell proliferation via p21, cyclin D1,
and b-catenin pathway (Wang and Friedman, 1998). Thus, SCFAs
have been reported to have important effects on intestinal
epithelial cell growth/differentiation and consequently on CRC
(Kles and Chang, 2006). However, there is a great debate about the
role of saturated, monounsaturated, and polyunsaturated (w-3 and
w-6) LCFAs in CRC, but few studies have been conducted on the
potency of LCFAs and/or specific LCFA metabolites in
modulating CRC cell line growth. Interestingly, our findings
show that unsaturated LCFAs were mitogenic at physiological
concentrations, whereas PUFAs such as EPA and DHA were




FIGURE 5 | Effect of PGE3, 12-S-HEPE, and LTB5 on Caco-2 cell growth.
Caco-2 cells were incubated for 48 h with PGE3 (0.1, 1, and 10 nM, line, dot, and
gray bars, respectively) or PGE3 (10 nM) plus SC19220 (SC, 60 nM) or AH 23848
(AH, 20 nM) or ONO-AE3-240 (ON, 2 nM) or with 12-S-HEPE (10, 100, and 1000
nM, line, gray, and dot bars, respectively) or with 12-S-HEPE (100 nM, gray bar)
plus U 75302 (U, 5 µM) or LY 255283 (LY, 25 µM) or ketoprofen (Kp, 5 µM). Cell
cultures were also incubated with LTB5 (1, 10,and 100 nM, dot, gray, and black
bars, respectively) or LTB4 (10 nM, gray bar) in absence of FBS. Finally, cells were
then counted (A, C, E) and DNA synthesis was measured (B, D). Data are
expressed as means ± SEM of three to four experiments performed in triplicate.
*P < 0.05 vs. Caco-2 cell cultures in the absence of FBS, #P < 0.05 vs. cells
incubated with 10 nM PGE3 or 12-S-HEPE.September 2020 | Volume 11 | Article 529976
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show any effects of Caco-2 cell growth.
Our findings show that monounsaturated LCFAs such as
palmitoleic and oleic acids are mitogenic in undifferentiated
Caco-2 cell cultures being oleic acid the most active. This effect
was also observed by the C18:1 trans, elaidic acid. These findings
agree with Petrik et al. (2000), that reported that Apcmin/+ mice feed
with oleic acid present a high number of intestinal tumors, and
recently, this mitogenic effect of oleic acid has also been observed in
prostate cancer cell growth (Liotti et al., 2018). Interestingly,
stearoyl-CoA desaturases expression and activity and the
subsequent conversion of saturated LCFA to monounsaturated
LCFA, were linked to CRC pathogenesis (Vargas et al., 2015; Igal,
2016), and consequently an accumulation of monounsaturated
LCFAs. It is important to note that oleic 10–100 mM is reached in
human plasma (Kopf and Schmitz, 2013).
Cancer cells are characterized by higher rates of lipid
biosynthesis in addition to increased glycolysis and lactateFrontiers in Pharmacology | www.frontiersin.org 7production than those of normal cells (Currie et al., 2013) as
well as high fatty acid uptake that require the expression of CD36,
over-expressed in the majority of tumor tissues (Kuemmerle et al.,
2011). This suggests that catabolism of FAs may be the dominant
bioenergetics source in cancer cells and, thus, be an important fuel
source for cell proliferation. Interestingly, our study reports data
that suggest an alternative mechanism to explain the mitogenic
action of oleic acid. Thus, our findings prompt that the mitogenic
effect of oleic acid appears dependent on LOX pathway
metabolism and the subsequent production of oleic acid
metabolites. Clapp et al. (2006) reported that lipoxygenation of
oleic acid gives allylic hydroperoxides followed by conversion to
enones. In this sense, Cabral et al. (2013 and 2015) reported that
LTs from AA and hydroxyoctadecanoid acids from linoleic acid
induced Caco-2 cell growth. Thus, we can consider the possible
implication of a LOX pathway oleic-derived metabolite in these
events. Guerrero et al. (1997) reported that 10-HODE is
biosynthesized from oleic acid by microbial oxidation that ClappFIGURE 6 | Effect of 10-HODE on Caco-2 cell growth and DNA synthesis. 10-HODE was incubated with Caco-2 cells without FBS in presence of U75302 (U75,
5 µM), LY25283 (LY25, 25 µM), or MK571 (MK5, 25 µM) for 48 h and then cells were counted or DNA synthesis assayed by cell BrdU incorporation. Results are
expressed as mean ± SEM (n = 6–9) *P < 0.05 vs control group (cells cultured without FBS), #P < 0.05 vs 10-HODE (100 nM), N.D., non determined.TABLE 2 | Effect of eicosanoids (PGE3 and 12-S-HEPE) and 10-HODE on cell signaling.
O.D. (450 nm)
Pathway Control PGE2 PGE3 12-S-HEPE 10-HODE
AKT1 0.18 ± 0.04 0.25 ± 0.04 0.23 ± 0.03 0.19 ± 0.02 0.21 ± 0.03
AKT2 0.17 ± 0.02 0.19 ± 0.02 0.18 ± 0.03 0.21 ± 0.01 0.19 ± 0.02
P38a 0.42 ± 0.04 0.92 ± 0.04* 0.99 ± 0.05* 0.85 ± 0.03* 0.83 ± 0.04*
GSKb 0.19 ± 0.03 0.56 ± 0.08* 0.52 ± 0.07* 0.48 ± 0.04* 0.50 ± 0.06*
CREB 0.21 ± 0.02 0.82 ± 0.11* 0.85 ± 0.12* 0.76 ± 0.13* 0.69 ± 0.10*
ERK 1/2 0.37 ± 0.03 1.06 ± 0.12* 0.99 ± 0.11* 0.95 ± 0.14* 0.89 ± 0.13*September 2020 | Volume 11 | ACaco-2 cells were incubated with PGE2 or PGE3 (10 nM), 12-S-HEPE (100 nM), or 10-HODE (100 nM) for 5 or 15 min, cells were then collected and finally phosphorylated AKT1, AKT2,
p38a, GSKb, CREB, and ERK 1/2 were measured as described in the Material and Methods section and expressed as optical density (450 nm). Data are expressed as means ± SEM of
two to four experiments performed in triplicate. *P < 0.05 vs. Caco-2 cell cultures in the absence of FBS.rticle 529976
Storniolo et al. LCFAs and Intestinal Epithelial Cell Growthet al. (2006) attributed to LOX activity. The reversion of the
mitogenic effects of oleic acid by LOX inhibitors suggest, by the
first time in mammalian cells, that oleic acid is metabolized by
LOXs and that 10-HODE or other oleic acid metabolite can be
responsible, at least in part, of Caco-2 cell growth induced by
this FA. Recently, we reported that LTs, HETEs, and
hydroxyoctadecadienoic acids (Cabral et al., 2014; Cabral et al.,
2015), with structural similarity to 10-HODE, have proliferative
effects through BLT interaction and the subsequent COX-pathway
activation. This study shows that 10-HODE from oleic acid was
also able to induce proliferative cell signaling pathways and Caco-2
cell growth through common mechanisms with LTs and HETEs
(Cabral et al., 2014; Cabral et al., 2015). Future studies should be
designed to demonstrate 10-HODE synthesis by intestinal
epithelial cells. Interestingly, Barone and co-workers (2014)
observed a decrease in polyp number and polyp volume by olive
oil diet. These apparent discrepancies put into consideration the
fact that oleic acid and olive oil can exert different effect on CRC
cell line growth considering that olive oil is a complex mix content
bioactive compounds that can modulate oleic acid action. In this
context, we recently reported that some minor compounds of
extra virgin olive oil modulate the mitogenic effects of oleic acid on
Caco-2 cells (Storniolo et al., 2019).
Dommels et al. (2002) reported that AA and EPA (10–100
µM) induced Caco-2 cell growth inhibition and cytotoxicity
through peroxidation products generated during lipid
peroxidation and COX activity. In agreement with these
authors, we observed that other PUFAs such as a- and g-
linolenic and DHA were able to reduce cell number and that
these findings were related with their capacity to induced
apoptosis (mitochondrial membrane potential variation, DNA
fragmentation) and binding to PPARg, an event that Giros et al.
(2009) did not consider involved in the apoptotic mechanism
of w-3 PUFAs on Caco-2 cells. These findings suggest a role of
intrinsic pathway of apoptosis in the pro-apoptotic actions of
these PUFAs. Interestingly, our findings indicate that although
EPA as well as linoleic, a- and g-linolenic, AA, and DHA are
apoptotic at the highest concentration (around 100 µM) as was
reported previously (Zhang et al., 2015; Storniolo, 2017), EPA
and DHA have a mitogenic effect at 1–10 µM. In addition, we
observed that this mitogenic effect of EPA is COX- and LOX-
pathway dependent, suggesting that EPA metabolites could be
involved in this event.
Experimental studies have shown that diets rich in fish oil
significantly reduce the amount of AA present in membrane
phospholipids (Mitjavila et al., 1996) and consequently the
synthesis of AA metabolites such as PGE2 (Moreno et al.,
2001), but increase the release of EPA metabolites. Even
though the theory of formation of the 3-series PGs by EPA has
been studied for decades, we still do not fully understand the role
of EPA metabolites such as PGE3 in cancer cells (Yang et al.,
2014). Here, we observed, for the first time, that PGE3 increased
cell growth and DNA synthesis in non-differentiated intestinal
epithelial cells at concentrations reached in Caco-2 cell cultures
supplemented with EPA. Thus, PGE3 presents a proliferativeFrontiers in Pharmacology | www.frontiersin.org 8action in a similar form to PGE2 at nM concentrations that could
be reached in colonic tissue as consequence of the immune cell
eicosanoid biosynthesis (Le Faouder et al., 2013). These findings
are, apparently, in disagreement with Fan et al. (2014) who
reported that PGE3 diminished the ability to support colonic
stem cell expansion but using a non-physiological concentration
(10 µM). Furthermore, we demonstrated that this PGE3
proliferative effect was a consequence of interaction with the
PGE2 receptors EP1 and EP4, in agreement with their affinities
(Moreno, 2017), and with a recent report showing similar effects
of both PGs on the disruption of the intestinal epithelial barrier
function (Rodriguez-Lagunas et al., 2013). Moreover, we
observed that cell signaling pathways involved in the mitogenic
action of PGE3 are like those involved in PGE2 action (Cabral
et al., 2013), being p38a, CREB, and ERK 1/2 pathways involved
in the mitogenic action of PGE3.
HETEs have mitogenic effect on different types of cells and are
also involved in the pathogenesis of cancer (Moreno, 2009).
Recently, 12-S-HETE was reported to have a proliferative effect
on Caco-2 cells (Cabral et al., 2013). To our knowledge, this is the
first study to show that 12-S-HEPE from EPA has similar effect on
intestinal epithelial cell growth with the implication of ERK 1/2,
CREB, or P38a pathways. No specific cellular receptors for HETEs/
HEPEs have been identified to date. However, it has been reported
that the binding of 12-HETE to the BLT2 receptor may be involved
in its mitogenic action (Cabral et al., 2013). Here, we demonstrate
that Caco-2 cell growth induced by 12-S-HEPE can be reverted by
BLT1 and BLT2 antagonists and a COX inhibitor, which suggests
that the 12-S-HEPE mitogenic action is, at least partly, due to PGs
synthesis after 12-S-HEPE interaction with both BLT receptors; a
mechanism previously described for LTB4 and 12-HETE (Cabral
et al., 2013) and 13-R-hydroxyoctadecadienoic acid (44),
compounds structurally related with 12-S-HEPE.
EPA administered to patients with Crohn’s disease (Ikehata
et al., 1992) or ulcerative colitis (Salomon et al., 1990) increases
the generation of LTB5 and the LTB5-LTB4 ratio, which were
related with an improvement in these patients. In our study,
LTB5 had no proliferative effect, while LTB4 significantly induced
Caco-2 cell growth, findings in agreement with Bortuzzo et al.
(1996) who found a lower affinity of LTB5 to the receptor of
LTB4. Moreover, since the treatment with 5-LOX inhibitor or
cysteinyl LT receptor antagonist reduced the mitogenic effect of
EPA, these results indirectly suggest that 5-series cysteinyl LTs
could also be involved, at least in part, in the mitogenic EPA
effects, in our experimental conditions. There is little literature
about the affinity of EPA derived LTs and cysteinyl LT receptors
but Wallace and McKnight (1990) reported that LTC5 or LTD5
have biological activity although less potent than LTs derived
from AA. Furthermore, although LTB5 did not have the
mitogenic effect of its AA-derived partners, PGE3 and 12-S-
HEPE have considerable mitogenic effects on intestinal epithelial
Caco-2 cells and may be involved in cell proliferation induced by
EPA. The role of COX and/or LOX pathway on cancer cell line
growth has been reported using cell lines such as HT-29,
HCA7, or LoVo (Hawcroft et al., 2010; Ganesh et al., 2012;September 2020 | Volume 11 | Article 529976
Storniolo et al. LCFAs and Intestinal Epithelial Cell GrowthLi et al., 2018). However, to our knowledge, it is the first time to
report the effect of PGE3, LTB5, and 12-S-HEPE derived from
EPA on epithelial cell growth. However, we believe that future
research should analyze the role of EPA and EPA eicosanoids on
non-transformed intestinal epithelial cell growth as well as
intestinal epithelium development using in vitro and in vivo
experimental models. Furthermore, it will be interesting to study
the role of DHA metabolites to explain the proliferative effect of
this PUFA at low concentrations.
In conclusion, the results obtained herein demonstrated that
oleic acid is a potent mitogenic factor to undifferentiated Caco-2
cells probably through LOX pathway metabolite such as 10-Frontiers in Pharmacology | www.frontiersin.org 9HODE whereas PUFAs such as EPA or DHA have a dual
behavior effect on Caco-2 cell growth depending on the FA
concentration (Figure 7). A high concentration of EPA/DHA
induced apoptosis, a process related with its binding to PPARg.
Meanwhile, low EPA concentration induced Caco-2 cell
proliferation that could be related to the synthesis of mitogenic
eicosanoids such as PGE3 and 12-HEPE and the subsequent
induction of mitogenic cell signaling pathways. Obviously, these
conclusions do not exclude a direct effect of LCFA (oleic acid and
EPA) or LCFA metabolites on Caco-2 cell growth through bind
to GPR40 and the subsequent cell signaling activation involved
in cell proliferation (Hass et al., 1997; Liu et al., 2013) or GPR120
that is abundantly expressed in intestine (Hirasawa et al., 2005;
Wu et al., 2013), it is activated by LCFAs (Hirasawa et al., 2005)
and is involved in the mitogenic effects of PUFAs (Hass et al.,
1997). Thus, this study contributes to open new perspectives to
understand the complicated relationship between fat ingest
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